-

SONIC AUTOMOTIVE INVESTIGATION INITIATED By Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Sonic Automotive, Inc. - SAH

NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces that KSF has commenced an investigation into Sonic Automotive, Inc. (NYSE: SAH).

On October 7, 2020, news sources reported that the Company’s Chief Executive Officer, David Bruton Smith, had been arrested and charged with felony assault by strangulation and misdemeanor charges of false imprisonment, assault on a female, and interfering with emergency communication. Shortly thereafter, the Company’s Board of Directors issued a statement affirming that the Company “remains steadfast in its support of [its] CEO.”

Then, on March 1, 2021, news sources reported that Smith had been indicted by a Mecklenburg County, N.C. grand jury on all four charges related to the October 2020 arrest, according to the Mecklenburg County District Attorney's Office.

KSF’s investigation is focusing on whether Sonic’s officers and/or directors breached their fiduciary duties to Sonic’s shareholders or otherwise violated state or federal laws.

If you have information that would assist KSF in its investigation, or have been a long-term holder of Sonic shares and would like to discuss your legal rights, you may, without obligation or cost to you, call toll-free at 1-877-515-1850 or email KSF Managing Partner Lewis Kahn (lewis.kahn@ksfcounsel.com), or visit https://www.ksfcounsel.com/cases/nyse-sah/ to learn more.

About Kahn Swick & Foti, LLC

KSF, whose partners include former Louisiana Attorney General Charles C. Foti, Jr., is one of the nation’s premier boutique securities litigation law firms. KSF serves a variety of clients – including public institutional investors, hedge funds, money managers and retail investors – in seeking to recover investment losses due to corporate fraud and malfeasance by publicly traded companies. KSF has offices in New York, California and Louisiana.

To learn more about KSF, you may visit www.ksfcounsel.com.

Contacts

Kahn Swick & Foti, LLC
Lewis Kahn, Managing Partner
lewis.kahn@ksfcounsel.com
1-877-515-1850

Industry:

Kahn Swick & Foti, LLC

NYSE:SAH
Release Versions
English

Contacts

Kahn Swick & Foti, LLC
Lewis Kahn, Managing Partner
lewis.kahn@ksfcounsel.com
1-877-515-1850

More News From Kahn Swick & Foti, LLC

Rallybio Investor Alert: Kahn Swick & Foti, LLC Investigates Merger of Rallybio Corporation - RLYB

NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed merger of Rallybio Corporation (NasdaqCM: RLYB) and Candid Therapeutics, Inc. Upon completion of the proposed transaction, Rallybio shareholders are expected to own approximately 3.65% of the combined company. KSF is seeking to determine whether the merger and the process that led to it are adequate, or whether the me...

AES Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of The AES Corporation - AES

NEW YORK CITY & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of The AES Corporation (NYSE: AES) to a consortium led by Global Infrastructure Partners and the EQT Infrastructure VI fund. Under the terms of the proposed transaction, shareholders of AES will receive $15.00 in cash for each share of AES that they own. KSF is seeking to determine whether this co...

Select Medical Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Select Medical Holdings Corporation - SEM

NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Select Medical Holdings Corporation (NYSE: SEM) to a consortium led by Select Medical executives and directors. Under the terms of the proposed transaction, shareholders of Select Medical will receive $16.50 in cash for each share of Select Medical that they own. KSF is seeking to determine whether...
Back to Newsroom